Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Introduction to Hemostasis01:05

Introduction to Hemostasis

9.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.8K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

58
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
58
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

10.1K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.1K
Disorders of Hemostasis01:24

Disorders of Hemostasis

1.3K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
1.3K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

7.7K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preventing Post-induction Hypotension During General Anaesthesia: A Dose-Response Study of Ringer's Lactate Guided by the Inferior Vena Cava Collapsibility Index.

Cureus·2026
Same author

H3K27M-altered diffuse midline glioma: Experience and outcomes from a low-middle income country setting in the contemporary era.

Neuro-oncology advances·2026
Same author

Cost-Utility Analysis of Indocyanine Green Versus Methylene Blue for Sentinel Lymph Node Biopsy in Breast Cancer.

Journal of surgical oncology·2026
Same author

B(C<sub>6</sub>F<sub>5</sub>)<sub>3</sub>-Catalyzed Chemical Tagging of Bioactive <i>N</i>-Alkylamines through β-Amino C(sp<sup>3</sup>)-H Functionalization.

Organic letters·2026
Same author

Hand Deserve Better: global clinical consensus recommendations on surgical gloving practice.

The Journal of hospital infection·2026
Same author

Clinical Outcomes and Prognostic Features of Diffuse Hemispheric Glioma, H3 G34-Mutant: An International Multi-institutional Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Related Experiment Video

Updated: Oct 16, 2025

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.4K

The Use of Hemostatic Agents to Decrease Bleeding Complications in General Plastic Surgery Procedures.

Joshua A Bloom1, Zachary Erlichman2, Sina Foroutanjazi2

  • 1Department of Surgery, Tufts Medical Center, Boston, Mass.

Plastic and Reconstructive Surgery. Global Open
|October 20, 2021
PubMed
Summary
This summary is machine-generated.

Hemostatic agents significantly reduce Jackson-Pratt drain use and postoperative complications in plastic surgery. This study found fewer hematomas and seromas with hemostatic agents, improving patient outcomes.

More Related Videos

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

5.4K
Bloodless Laparoscopic Partial Splenectomy Assisted by Bipolar Radiofrequency Excision Hemostatic Device
04:40

Bloodless Laparoscopic Partial Splenectomy Assisted by Bipolar Radiofrequency Excision Hemostatic Device

Published on: November 4, 2022

1.2K

Related Experiment Videos

Last Updated: Oct 16, 2025

Application of Hemostatic Devices in Laparoscopic Hepatectomy
04:23

Application of Hemostatic Devices in Laparoscopic Hepatectomy

Published on: April 19, 2022

2.4K
A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

5.4K
Bloodless Laparoscopic Partial Splenectomy Assisted by Bipolar Radiofrequency Excision Hemostatic Device
04:40

Bloodless Laparoscopic Partial Splenectomy Assisted by Bipolar Radiofrequency Excision Hemostatic Device

Published on: November 4, 2022

1.2K

Area of Science:

  • Plastic Surgery
  • Surgical Complications
  • Hemostasis

Background:

  • Hematomas and seromas are common complications in plastic surgery, impacting wound healing.
  • Hemostatic agents are increasingly explored to improve traditional hemostasis methods.

Purpose of the Study:

  • To evaluate the impact of hemostatic agents on postoperative bleeding complications.
  • To assess the duration of Jackson-Pratt drain use in plastic surgery with and without hemostatic agents.

Main Methods:

  • Retrospective chart review of patients undergoing breast reduction, panniculectomy, or abdominoplasty.
  • Comparison of outcomes between groups using fibrin sealant (FS) or combination powder (CP) versus no hemostatic agent.
  • Data collected included complications, drain removal time, and type of hemostatic agent used.

Main Results:

  • Hemostatic agent use correlated with reduced Jackson-Pratt drain duration and fewer overall complications.
  • The hemostatic agent groups showed a trend towards fewer hematomas and seromas.
  • Combination powder (CP) demonstrated significantly shorter drain duration in breast reduction compared to fibrin sealant (FS).

Conclusions:

  • Hemostatic agents may decrease postoperative complications in general plastic surgery.
  • The use of hemostatic agents can significantly reduce the time to Jackson-Pratt drain removal.